RIVASTIGMINA ARISTO 13,3 MG/24 H PARCHES TRANSDERMICOS EFG

Aristo Pharma Iberia S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 71dc747b4f9eb000
Drug Cima Aemps Name: RIVASTIGMINA ARISTO 13,3 MG/24 H PARCHES TRANSDERMICOS EFG
Register Number: 85465
Holder Company Name: Aristo Pharma Iberia S.L.
Marketing Company Name: Aristo Pharma Iberia S.L.
Authorization Date: 2020-11-20
Dosage Form: PARCHE TRANSDÉRMICO
Dose: 13,3 mg/24 h
Route Of Administration: VÍA TRANSDÉRMICA
Prescription Type: Diagnóstico Hospitalario
Commercialized: Yes
Company Name: Aristo Pharma Iberia S.L.

RIVASTIGMINA

19,2 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 20, 2020

Approval ID

71dc747b4f9eb000

Type

Standard